Modelling: when and why?

被引：13

作者：

Laruelle, M ^{[1
]}

机构：

[1] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Unit 42, New York, NY 10027 USA

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1999年 / 26卷 / 06期

关键词：

D O I：

10.1007/s002590050423

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

收藏

页码：571 / 572

页数：2

相关论文

共 15 条

[1] ABI-DARGHAM A, 1995, J NUCL MED, V36, P167
[2] WORKSHOP ON SCHIZOPHRENIA, PET, AND DOPAMINE D2 RECEPTORS IN THE HUMAN NEOSTRIATUM
ANDREASEN, NC
CARSON, R
DIKSIC, M
EVANS, A
FARDE, L
GJEDDE, A
HAKIM, A
LAL, S
NAIR, N
SEDVALL, G
TUNE, L
WONG, D
[J]. SCHIZOPHRENIA BULLETIN, 1988, 14 (03) : 471 - 484
[3] CARSON RE, 1991, J NUCL MED, V32, P2206
[4] Chan GLY, 1998, J NUCL MED, V39, P792
[5] Chan GLY, 1999, J NUCL MED, V40, P283
[6] QUANTITATIVE-ANALYSIS OF D2 DOPAMINE RECEPTOR-BINDING IN THE LIVING HUMAN-BRAIN BY PET
FARDE, L
HALL, H
EHRIN, E
SEDVALL, G
[J]. SCIENCE, 1986, 231 (4735) : 258 - 261
[7] Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET
Gunn, RN
Sargent, PA
Bench, CJ
Rabiner, EA
Osman, S
Pike, VW
Hume, SP
Grasby, PM
Lammertsma, AA
[J]. NEUROIMAGE, 1998, 8 (04) : 426 - 440
[8] Comparison of methods for analysis of clinical [C-11]raclopride studies
Lammertsma, AA
Bench, CJ
Hume, SP
Osman, S
Gunn, K
Brooks, DJ
Frackowiak, RSJ
[J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1996, 16 (01) : 42 - 52
[9] Laruelle M, 1998, Q J NUCL MED, V42, P211
[10] LAURUELLE M, 1997, NEUROPSYCHOPHARMACOL, V17, P162